Enabling Precision Medicine At Scale Through Digital Innovation And AI

September 1, 2025

AI in Clinical Trials: Powered by Digital Foundations

Biopharmaceutical R&D continues to expand, with more drug candidates entering development each year. Yet, the path to market remains a complex, costly, and data-intensive process. Artificial intelligence offers a way to accelerate this journey — from smarter patient selection to adaptive trial designs — enabling faster development cycles and more targeted therapies.

But AI’s success depends on a strong digital foundation. Clean, harmonized, well-structured, and metadata-rich data — supported by cloud-based platforms — are essential to unlock its full potential.

With AI as the engine and digital platforms as the vehicle, this transformation turns data from a challenge into a strategic asset — delivering the right therapies to the right patients, faster and more precisely.